Skip to content
Home / Companies / NRIX NRI
Nurix Therapeutics, Inc. (NRIX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest NRIX Insider Trades
About Nurix Therapeutics, Inc. (NRIX) Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Headquarters BRISBANE, CA
Employees 357
Listed 2020
Exchange XNAS https://www.nurixtx.com SEC filings for NRIX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 12 89,485 $1.93M Option exercise 30 159,384
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
NRIX Insider Transactions (Form 4) 83 59 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 4, 2026 GH Gwenn Hansen - Officer Open-market sale Common Stock 1,500
Recent NRIX Form 8-K Filings 5
Recent NRIX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 5, 2026 GWENN HANSEN Officer 8,712 $215K View on EDGAR Aug 4, 2026 GWENN M HANSEN Officer
NRIX Insider Trading - FAQ
What is the latest insider trade for NRIX? Nurix Therapeutics, Inc. (NRIX) had 10 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for NRIX runs to 59 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying NRIX stock? No insider purchases of NRIX were filed in the last 90 days.
How many insiders are selling NRIX stock? 12 insider sales of NRIX were filed in the last 90 days, totaling $1.93M.
Where can I see NRIX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks NRIX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow NRIX insider buys? Create a free InsiderAlpha account and press Watch on this page to add NRIX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track NRIX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $64K
Market cap $2.72B
P/E ratio -
Dividend yield -
Average volume 1.97M
52 week high $28.23
52 week low $8.20
Today's high -
Today's low -
Open -
Volume -
Previous close $26.21
Shares outstanding 103.78M Market cap
$2.72B
357 employees
NRIX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 12 sales totaling $1.93M.
Most-Active NRIX Insiders - Last 90 Days 10 Aug 4, 2026 GH Gwenn Hansen - Officer Open-market sale Common Stock 2,611 $24.64 $64K
Aug 4, 2026 HV Houte Hans van - Officer Open-market sale Common Stock 1,794 $23.89 $43K
Aug 4, 2026 HV Houte Hans van - Officer Open-market sale Common Stock 2,967 $24.65 $73K
Aug 3, 2026 CR Christine Ring - Officer Option exercise Common Stock 5,787 $8.72 $50K
Aug 3, 2026 CR Christine Ring - Officer Open-market sale Common Stock 16,589 $23.05 $382K
Aug 3, 2026 CR Christine Ring - Officer Option exercise Employee Stock Option (right to buy) 5,787 $0.00 -
Jul 30, 2026 HV Houte Hans van - Officer Option exercise Common Stock 3,750 $0.00 -
Jul 30, 2026 HV Houte Hans van - Officer Option exercise Common Stock 2,858 $0.00 -
Jul 30, 2026 HV Houte Hans van - Officer Option exercise Common Stock 3,572 $0.00 -
Jul 30, 2026 HV Houte Hans van - Officer Open-market sale Common Stock 2,845 $23.38 $67K
Jul 30, 2026 HV Houte Hans van - Officer Option exercise Restricted Stock Units 3,750 $0.00 -
Jul 30, 2026 HV Houte Hans van - Officer Option exercise Restricted Stock Units 2,858 $0.00 -
Jul 30, 2026 HV Houte Hans van - Officer Option exercise Restricted Stock Units 3,572 $0.00 -
Jul 30, 2026 CR Christine Ring - Officer Option exercise Common Stock 3,750 $0.00 -
Jul 30, 2026 CR Christine Ring - Officer Option exercise Common Stock 2,858 $0.00 -
Jul 30, 2026 CR Christine Ring - Officer Option exercise Common Stock 3,572 $0.00 -
Jul 30, 2026 CR Christine Ring - Officer Open-market sale Common Stock 3,847 $23.38 $90K
Jul 30, 2026 CR Christine Ring - Officer Option exercise Restricted Stock Units 3,750 $0.00 -
Jul 30, 2026 CR Christine Ring - Officer Option exercise Restricted Stock Units 2,858 $0.00 -
Jul 30, 2026 CR Christine Ring - Officer Option exercise Restricted Stock Units 3,572 $0.00 -
Jul 30, 2026 GH Gwenn Hansen - Officer Option exercise Common Stock 3,750 $0.00 -
Jul 30, 2026 GH Gwenn Hansen - Officer Option exercise Common Stock 2,858 $0.00 -
Jul 30, 2026 GH Gwenn Hansen - Officer Option exercise Common Stock 3,572 $0.00 -
Jul 30, 2026 GH Gwenn Hansen - Officer Open-market sale Common Stock 3,847 $23.38 $90K
Jul 30, 2026 GH Gwenn Hansen - Officer Option exercise Restricted Stock Units 3,750 $0.00 -
Jul 30, 2026 GH Gwenn Hansen - Officer Option exercise Restricted Stock Units 2,858 $0.00 -
Jul 30, 2026 GH Gwenn Hansen - Officer Option exercise Restricted Stock Units 3,572 $0.00 -
Jul 2, 2026 CR Christine Ring - Officer Option exercise Common Stock 5,221 $1.86 $10K
Jul 2, 2026 CR Christine Ring - Officer Option exercise Common Stock 5,787 $8.72 $50K
Jul 2, 2026 CR Christine Ring - Officer Open-market sale Common Stock 11,008 $23.56 $259K
Jul 2, 2026 CR Christine Ring - Officer Option exercise Employee Stock Option (right to buy) 5,221 $0.00 -
Jul 2, 2026 CR Christine Ring - Officer Option exercise Employee Stock Option (right to buy) 5,787 $0.00 -
Jun 25, 2026 GH Gwenn Hansen - Officer Open-market sale Common Stock 5,394 $20.00 $108K
Jun 25, 2026 CR Christine Ring - Officer Option exercise Common Stock 13,333 $7.26 $97K
Jun 25, 2026 CR Christine Ring - Officer Option exercise Common Stock 15,602 $8.72 $136K
Jun 25, 2026 CR Christine Ring - Officer Open-market sale Common Stock 28,935 $20.06 $581K
Jun 25, 2026 CR Christine Ring - Officer Option exercise Employee Stock Option (right to buy) 13,333 $0.00 -
Jun 25, 2026 CR Christine Ring - Officer Option exercise Employee Stock Option (right to buy) 15,602 $0.00 -
Jun 2, 2026 CR Christine Ring - Officer Option exercise Common Stock 3,422 $1.86 $6K
Jun 2, 2026 CR Christine Ring - Officer Open-market sale Common Stock 8,148 $16.60 $135K
Jun 2, 2026 CR Christine Ring - Officer Option exercise Employee Stock Option (right to buy) 3,422 $0.00 -
May 15, 2026 PS Paul M. Silva - Director Grant or award Director Stock Option (right to buy) 31,250 $0.00 -
May 15, 2026 ES Edward C. Saltzman - Director Grant or award Director Stock Option (right to buy) 31,250 $0.00 -
May 15, 2026 JR Judith A. Reinsdorf - Director Grant or award Director Stock Option (right to buy) 31,250 $0.00 -
May 15, 2026 DL David L. Lacey - Director Grant or award Director Stock Option (right to buy) 31,250 $0.00 -
May 15, 2026 AK Anil Kapur - Director Grant or award Director Stock Option (right to buy) 31,250 $0.00 -
May 15, 2026 RD Roger D. Dansey - Director Grant or award Director Stock Option (right to buy) 31,250 $0.00 -
May 15, 2026 RB Roy D. Baynes - Director Grant or award Director Stock Option (right to buy) 31,250 $0.00 -
May 15, 2026 JG Julia P. Gregory - Director Grant or award Director Stock Option (right to buy) 31,250 $0.00 -
May 5, 2026 HV Houte Hans van - Officer Open-market sale Common Stock 13,473 $16.58 $223K
May 5, 2026 HV Houte Hans van - Officer Open-market sale Common Stock 582 $17.18 $10K
May 4, 2026 CR Christine Ring - Officer Open-market sale Common Stock 8,148 $16.96 $138K
May 1, 2026 CR Christine Ring - Officer Open-market sale Common Stock 5,394 $16.76 $90K
Apr 30, 2026 HV Houte Hans van - Officer Option exercise Common Stock 2,000 $0.00 -
Apr 30, 2026 HV Houte Hans van - Officer Option exercise Common Stock 3,750 $0.00 -
Apr 30, 2026 HV Houte Hans van - Officer Option exercise Common Stock 2,858 $0.00 -
Apr 30, 2026 HV Houte Hans van - Officer Open-market sale Common Stock 2,388 $16.65 $40K
Apr 30, 2026 HV Houte Hans van - Officer Option exercise Restricted Stock Units 2,000 $0.00 -
Apr 30, 2026 HV Houte Hans van - Officer Option exercise Restricted Stock Units 3,750 $0.00 -
Apr 30, 2026 HV Houte Hans van - Officer Option exercise Restricted Stock Units 2,858 $0.00 -
Apr 30, 2026 CR Christine Ring - Officer Option exercise Common Stock 2,000 $0.00 -
Apr 30, 2026 CR Christine Ring - Officer Option exercise Common Stock 3,750 $0.00 -
Apr 30, 2026 CR Christine Ring - Officer Option exercise Common Stock 2,858 $0.00 -
Apr 30, 2026 CR Christine Ring - Officer Open-market sale Common Stock 3,214 $16.65 $53K
Apr 30, 2026 CR Christine Ring - Officer Option exercise Restricted Stock Units 2,000 $0.00 -
Apr 30, 2026 CR Christine Ring - Officer Option exercise Restricted Stock Units 3,750 $0.00 -
Apr 30, 2026 CR Christine Ring - Officer Option exercise Restricted Stock Units 2,858 $0.00 -
Apr 30, 2026 GH Gwenn Hansen - Officer Open-market sale Common Stock 3,214 $16.65 $53K
Apr 30, 2026 GH Gwenn Hansen - Officer Option exercise Common Stock 2,000 $0.00 -
Apr 30, 2026 GH Gwenn Hansen - Officer Option exercise Common Stock 3,750 $0.00 -
Apr 30, 2026 GH Gwenn Hansen - Officer Option exercise Common Stock 2,858 $0.00 -
Apr 30, 2026 GH Gwenn Hansen - Officer Option exercise Restricted Stock Units 2,000 $0.00 -
Apr 30, 2026 GH Gwenn Hansen - Officer Option exercise Restricted Stock Units 3,750 $0.00 -
Apr 30, 2026 GH Gwenn Hansen - Officer Option exercise Restricted Stock Units 2,858 $0.00 -
Apr 2, 2026 CR Christine Ring - Officer Open-market sale Common Stock 8,148 $15.24 $124K
Mar 2, 2026 CR Christine Ring - Officer Open-market sale Common Stock 8,148 $15.44 $126K
Feb 10, 2026 HV Houte Hans van - Officer Grant or award Employee Stock Option (right to buy) 93,750 $0.00 -
Feb 10, 2026 HV Houte Hans van - Officer Grant or award Restricted Stock Units 42,875 $0.00 -
Feb 10, 2026 GH Gwenn Hansen - Officer Grant or award Employee Stock Option (right to buy) 93,750 $0.00 -
Feb 10, 2026 GH Gwenn Hansen - Officer Grant or award Restricted Stock Units 42,875 $0.00 -
Feb 10, 2026 AS Arthur T. Sands - Officer Grant or award Employee Stock Option (right to buy) 562,500 $0.00 -
Feb 9, 2026 CR Christine Ring - Officer Open-market sale Common Stock 14,261 $16.66 $238K
$NUVL
Nuvalent, Inc.
$IONS
IONIS PHARMACEUTICALS INC
